Effects of Telemonitoring in Quality of Life Amongst Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
CancerTelemonitoringTelemedicineSymptoms and SignsQuality of Life
Interventions
DEVICE

Contigo Application

Contigo, a smartphone app, focuses on two main goals: monitoring cancer patients for early signs of drug toxicity and offering educational content to empower them in managing clinical challenges linked to their diagnosis and treatment. Monitoring involves patients inputting experiences via oncology-related questionnaires, with weekly checks for chemotherapy toxicity using a validated questionnaire (PRO-CTCAE). Severe cases trigger alerts, while milder ones receive educational guidance. Data collected is shared with healthcare providers. Educational content, backed by scientific evidence and expert collaboration, covers cancer-specific topics and healthcare processes to enhance patients' self-awareness and self-care practices.

Trial Locations (1)

Unknown

RECRUITING

UC Christus Cancer Centre, Santiago

All Listed Sponsors
collaborator

Centro para la Prevención y Control del Cáncer (CECAN), Santiago, Chile

UNKNOWN

lead

Universidad Nacional Andres Bello

OTHER